BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16139485)

  • 1. Ziprasidone in the treatment of Parkinson's disease psychosis.
    Shiah IS; Lin CL; Mao WC; Luu SU
    Eur Psychiatry; 2006 Dec; 21(8):578-9. PubMed ID: 16139485
    [No Abstract]   [Full Text] [Related]  

  • 2. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziprasidone and psychosis in Parkinson disease.
    Micheli F; Taubenslag N; Gatto E; Scorticati MC
    Clin Neuropharmacol; 2005; 28(5):254. PubMed ID: 16239772
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of ziprasidone in parkinsonian patients with psychosis.
    Gómez-Esteban JC; Zarranz JJ; Velasco F; Lezcano E; Lachen MC; Rouco I; Barcena J; Boyero S; Ciordia R; Allue I
    Clin Neuropharmacol; 2005; 28(3):111-4. PubMed ID: 15965308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
    Pintor L; Valldeoriola F; Baillés E; Martí MJ; Muñiz A; Tolosa E
    Clin Neuropharmacol; 2012; 35(2):61-6. PubMed ID: 22388466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
    Brieger P
    J Clin Psychiatry; 2004 Jan; 65(1):132-5. PubMed ID: 14744182
    [No Abstract]   [Full Text] [Related]  

  • 7. Ziprasidone augmentation of clozapine in 11 patients.
    Kaye NS
    J Clin Psychiatry; 2003 Feb; 64(2):215-6. PubMed ID: 12633133
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrocardiographic changes with ziprasidone.
    Loebel A; Miceli J; Chappell P; Siu C
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic treatment of psychosis associated with multiple sclerosis.
    Davids E; Hartwig U; Gastpar M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):743-4. PubMed ID: 15276702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziprasidone and migraine headache.
    Boeker T
    Am J Psychiatry; 2002 Aug; 159(8):1435-6. PubMed ID: 12153843
    [No Abstract]   [Full Text] [Related]  

  • 11. Ziprasidone-induced tardive dyskinesia.
    Mendhekar DN
    Can J Psychiatry; 2005 Aug; 50(9):567-8. PubMed ID: 16262114
    [No Abstract]   [Full Text] [Related]  

  • 12. Ziprasidone induced symptomatic bradycardia: a case report.
    Menon V; Kattimani S; Ayyanar S
    Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with ziprasidone.
    Patel NC; Sierk P; Dorson PG; Crismon L
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495. PubMed ID: 12014778
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
    Schindehütte J; Trenkwalder C
    Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease].
    López del Val LJ; Santos S
    Rev Neurol; 2004 Oct 1-15; 39(7):661-7. PubMed ID: 15490355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
    Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
    Gray NS
    Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
    Barak Y; Mazeh D; Plopski I; Baruch Y
    Am J Geriatr Psychiatry; 2006 Jul; 14(7):629-33. PubMed ID: 16816018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.
    Yang SH; McNeely MJ
    Am J Psychiatry; 2002 Aug; 159(8):1435. PubMed ID: 12153844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.